Patent · US Active

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

US10233142B2 · kind B2 · utility

0Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 8, 2017
Grant dateMar 19, 2019
Priority date—
Expiry dateDec 8, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Isolated metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-methyl]propanamide, methods for their use, and compositions containing the metabolites.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.